Contractile force is enhanced in aortas from pendrin null mice due to stimulation of angiotensin II-dependent signaling

PLoS ONE

Volumn 9, Issue 8, 2014, Pages

  Sutliff, Roy L ^a,b   Walp, Erik R ^a,b   Kim, Young Hee ^b   Walker, Lori A ^c   El Ali, Alexander M ^a,b   Ma, Jing ^a,b   Bonsall, Robert ^b   Ramosevac, Semra ^d   Eaton, Douglas C ^d   Verlander, Jill W ^e   Hansen, Laura ^f   Gleason Jr , Rudolph L ^f   Pham, Truyen D ^b   Hong, Seongun ^b   Pech, Vladimir ^b   Wall, Susan M ^b,d  

^a ATLANTA VA MEDICAL CENTER   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF COLORADO   (United States)

^d EMORY UNIVERSITY   (United States)

^e UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^f GEORGIA INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN II; CALCIUM ION; CANDESARTAN; CATECHOLAMINE; CONTRACTILE PROTEIN; NITRIC OXIDE; PENDRIN; PHENYLEPHRINE; POTASSIUM CHLORIDE; ANION TRANSPORT PROTEIN; CALCIUM; MESSENGER RNA; SLC26A4 PROTEIN, MOUSE; VASOCONSTRICTOR AGENT;

ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE; BLOOD VESSEL REACTIVITY; CATECHOLAMINE SYNTHESIS; CONTROLLED STUDY; GENE EXPRESSION; GENE FUNCTION; GENE LOCATION; HORMONAL REGULATION; MALE; MOUSE; MUSCLE STRENGTH; NONHUMAN; PENDRIN GENE; SIGNAL TRANSDUCTION; SMOOTH MUSCLE CONTRACTILITY; THORACIC AORTA; VASCULAR ENDOTHELIUM; WILD TYPE; ANIMAL; AORTA; BIOSYNTHESIS; DEFICIENCY; DOSE RESPONSE; DRUG EFFECTS; GENETICS; KIDNEY; KNOCKOUT MOUSE; METABOLISM; PATHOLOGY; VASCULAR SMOOTH MUSCLE; VASOCONSTRICTION;

ANGIOTENSIN II; ANIMALS; ANION TRANSPORT PROTEINS; AORTA; CALCIUM; CATECHOLAMINES; DOSE-RESPONSE RELATIONSHIP, DRUG; GENE EXPRESSION; KIDNEY; MALE; MICE; MICE, KNOCKOUT; MUSCLE, SMOOTH, VASCULAR; NITRIC OXIDE; PHENYLEPHRINE; POTASSIUM CHLORIDE; RECEPTOR, ANGIOTENSIN, TYPE 1; RNA, MESSENGER; SIGNAL TRANSDUCTION; VASOCONSTRICTION; VASOCONSTRICTOR AGENTS;

EID: 84929056290     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0105101     Document Type: Article

References (47)

1. Royaux IE, Wall SM, Karniski LP, Everett LA, Suzuki K, et al. (2001) Pendrin, encoded by the pendred syndrome gene, resides in the apical region of renal intercalated cells and mediates bicarbonate secretion. ProcNatlAcadSciUSA 98: 4221-4226. (Pubitemid 32249925)
2. Wall SM, Hassell KA, Royaux IE, Green ED, Chang JY, et al. (2003) Localization of pendrin in mouse kidney. AmJPhysiol 284: F229-F241. (Pubitemid 35471303)
3. Kim Y-H, Kwon T-H, Frische S, Kim J, Tisher CC, et al. (2002) Immunocytochemical localization of pendrin in intercalated cell subtypes in rat and mouse kidney. AmJPhysiol 283: F744-F754. (Pubitemid 35033962)
4. Wall SM, Kim Y-H, Stanley L, Glapion DM, Everett LA, et al. (2004) NaCl restriction upregulates renal Slc26a4 through subcellular redistribution: role in Cl- conservation. Hypertension 44: 1-6.
5. Verlander JW, Hassell KA, Royaux IE, Glapion DM, Wang M-E, et al. (2003) Deoxycorticosterone upregulates Pds (Slc26a4) in mouse kidney: role of pendrin in mineralocorticoid-induced hypertension. Hypertension 42: 356-362. (Pubitemid 37093485)
6. Pech V, Kim Y-H, Weinstein AM, Everett LA, Pham TD, et al. (2007) Angiotensin II increases chloride absorption in the cortical collecting duct in mice through a pendrin-dependent mechanism. AmJPhysiol 292: F914-F920. (Pubitemid 46393416)
7. Verlander JW, Hong S, Pech V, Bailey JL, Agazatian D, et al. (2011) Angiotensin II acts through the angiotensin 1a receptor to upregulate pendrin. AmJPhysiol 301: F1314-F1325.
8. Verlander JW, Kim Y-H, Shin WK, Pham TD, Hassell KA, et al. (2006) Dietary Cl- restriction upregulates pendrin expression within the apical plasma membrane of type B intercalated cells. AmJPhysiol 291: F833-F839. (Pubitemid 44506980)
9. Kim Y-H, Pech V, Spencer KB, Beierwaltes WH, Everett LA, et al. (2007) Reduced ENaC expression contributes to the lower blood pressure observed in pendrin null mice. AmJPhysiol 293: F1314-F1324. (Pubitemid 47583967)
10. Griffin SA, Brown WCB, MacPherson F, McGrath JC, Wilson VG, et al. (1991) Angiotensin II causes vascular hypertrophy in part by a non-pressor mechanism. Hypertension 17: 626-635.
11. Simon G, Illyes G (2001) Structural vascular changes in hypertension. Hypertension 37: 255-260.
12. Longhurst PA, Rice PJ, Taylor DA, Flemming WW (1988) Sensitivity of caudal arteries and the mesenteric vascular bed to norepinephrine in DOCA-salt hypertension. Hypertension 12: 133-142.
13. Brunner CA (1992) Vascular responsiveness in rats resistant to aldosterone-salt hypertension. Hypertension 20: 59-66.
14. Chamiot-Clerc P, Renaud JF, Safar ME (2001) Pulse pressure, aortic reactivity and endothelium dysfunction in old hypertensive rats. Hypertension 37: 313-321. (Pubitemid 32199093)
15. Tanaka M, Tsuchida S, Imai T, Fujii N, Miyazaki H, et al. (1999) Vascular response to angiotensin II is exaggerated through an upregulation of AT1 receptor in AT2 knockout mice. BiochemBiophysResCommun 258: 194-198. (Pubitemid 29287026)
16. Pech V, Pham TD, Hong S, Weinstein AM, Spencer KB, et al. (2010) Pendrin modulates ENaC function by changing luminal HCO3-. JAmSocNephrol 21: 1928-1941.
17. Everett LA, Belyantseva IA, Noben-Trauth K, Cantos R, Chen A, et al. (2001) Targeted disruption of mouse Pds provides insight about the inner-ear defects encountered in Pendred syndrome. Human Molecular Genetics 10: 153-161. (Pubitemid 32098125)
18. Sutliff RL, Weber CS, Qian J, Miller ML, Clemens TL, et al. (1999) Vasorelaxant properties of parathyroid hormone-related protein in the mouse: evidence for endothelium involvement independent of nitric oxide formation. Endocrinology 140: 2077-2083. (Pubitemid 30636445)
19. Lalli J, Harrer JM, Luo W, Kranias EG, Paul RJ (1997) Targeted ablation of the phospholamban gene is associated with a marked decrease in sensitivity in aortic smooth muscle. CircRes 80: 506-513. (Pubitemid 27137287)
20. McMahon EG, Paul RJ (1986) Effects of forskolin and cyclic nucleotides on isometric force in rat aorta. Am J Physiol 250: C468-473.
21. Zhao G, Sutliff RL, Weber CS, Wang J, Lorenz J, et al. (2001) Smooth muscle-targeted overexpression of insulin-like growth factor I results in enhanced vascular contractility. Endocrinology 142: 623-632. (Pubitemid 32222411)
22. McMahon EG, Paul RJ (1985) Calcium sensitivity of isometric force in intact and chemically skinned aortas during development of aldosterone-salt hypertension in the rat. CircRes 56: 427-435. (Pubitemid 15119519)
23. Wall SM, Knepper MA, Hassell KA, Fischer MP, Shodeinde A, et al. (2006) Hypotension in NKCC1 null mice: role of the kidneys. AmJPhysiol 290: F409-F416. (Pubitemid 43724994)
24. Kim Y-H, Pham TD, Zheng W, Hong S, Baylis C, et al. (2009) Role of pendrin in iodide balance: going with the flow. AmJPhysiol 297: 1069-1079.
25. Terris J, Ecelbarger CA, Nielsen S, Knepper MA (1996) Long-term regulation of four renal aquaporins in rats. AmJPhysiol 271: F414-F422.
26. Knauf F, Yang C-L, Thomson RB, Mentone SA, Giebisch G, et al. (2001) Identification of a chloride-formate exchanger expressed on the brush border membrane of renal proximal tubule cells. ProcNatlAcadSciUSA 98: 9425-9430. (Pubitemid 32743933)
27. Martin AF, Bhatti S, Pyne-Geithman GJ, Farjah M, Manaves V, et al. (2007) Expression and function of COOH-terminal myosin heavy chain isoforms in mouse smooth muscle. AmJPhysiol 293: C238-C245. (Pubitemid 47105020)
28. Ikebe M, Hewett TE, Martin AF, Chen M, Hartshorne DJ (1991) Cleavage of a smooth muscle myosin heavy chain near its C terminus by a-chymotrypsin. JBiolChem 266: 7030-7036.
29. Walker LA, MacDonald JA, Liu X, Nakamoto RK, Haystead TAJ, et al. (2001) Site-specific phosphorylation and point mutations of telokin modulate its Ca2+- desensitizing effect in smooth muscle. JBiolChem 276: 24519-24524.
30. Kaufmann PG, McMahon RP, Becker LC, Bertolet B, Bonsall R, et al. (1998) The psychophysiological investigations of myocardial ischemia (PIMI) study: objective, methods and variability of measures. PsychosomMed 60: 56-63. (Pubitemid 28124838)
31. Kilts CD, Gooch M, Knopes K (1984) Quantification of plasma catecholamines by online trace enrichment HPLC with electrochemical detection. JNeurosci-Methods 11: 257-273. (Pubitemid 15209731)
32. Goldberg AD, Becker LC, Bonsall R, Cohen JD, Ketterer MW, et al. (1996) Ischemic, hemodynamic and neurohormonal responses to mental and exercise stress. Experience from the Psychophysiological Investigations of Myochardial Ischemia Study (PIMI). Circulation 94: 2402-2409. (Pubitemid 26403565)
33. Chipperfield AR, Harper AA (2000) Chloride in smooth muscle. ProgBiophys-MolecBiol 74: 175-221. (Pubitemid 32168154)
34. Kojda G, Laursen JB, Ramasamy S, Kent JD, Kurz S, et al. (1999) Protein expression, vascular reactivity and soluble guanylate cyclase activity in mice lacking the endothelial cell nitric oxide synthase: contributions of NOS isoforms to blood pressure and heart rate control. CardiovascRes 42: 206-213. (Pubitemid 29167086)
35. Horowitz A, Menice CB, Laporte R, Morgan KG (1996) Mechanisms of smooth muscle contraction. PhysiolRev 76: 967-1003. (Pubitemid 26346813)
36. Maze M, Spiss CK, Tsujimoto G, Hoffman BB (1985) Epinephrine infusion induces hyporesponsiveness of vascular smooth muscle. Life Sciences 37: 1571-1578. (Pubitemid 15248389)
37. Rajagopalan S, Laursen JB, Borthayre A, Kurz S, Keiser J, et al. (1997) Role for endothelin-1 in angiotensin II-mediated hypertension. Hypertension 30: 29-34. (Pubitemid 27306343)
38. Schildmeyer LA, Braun R, Taffet G, Debiasi M, Burns AE, et al. (2000) Impaired vascular contractility and blood pressur homeostasis in the smooth muscle α-actin null mouse. FASEB J 14: 2213-2220.
39. Tang DD, Anfinogenova Y (2008) Physiologic properties and regulation of the actin cytoskeleton in vascular smooth muscle. JCardiovascPharmacolTher 13: 130-140. (Pubitemid 351704167)
40. Takeya K, Loutzenhiser K, Shiraishi M, Loutzenhiser R, Walsh MP (2008) A highly sensitive technique to measure myosin regulatory light chain phosphorylation: the first quantification in renal arterioles. AmJPhysiol 294: F1487-F1492.
41. Eddinger TJ, Meer DP (2007) Myosin II isoforms in smooth muscle: heterogeneity and function. AmJPhysiol 293: C493-C508. (Pubitemid 47235170)
42. Russell A, Watts S (2000) Vascular reactivity of isolated thoracic aorta of the C57BL/6J mouse. J Pharmacol Exp Ther 294: 598-604. (Pubitemid 30490834)
43. Zhou Y, Dirksen WP, Babu GJ, Periasamy M (2003) Differential vasoconstrictions induced by angiotensin II: role of AT1 and AT2 receptors in isolated C57BL/6J mouse blood vessels. Am J Physiol Heart Circ Physiol 285: H2797-2803. (Pubitemid 37443101)
44. Stapleton PA, James ME, Goodwill AG, Frisbee JC (2008) Obesity and vascular dysfunction. Pathophysiology 15: 79-89.
45. Wang D, Chabrashvili T, Borrego L, Aslam S, Umans JG (2006) Angiotensin II infusion alters vascular function in mouse resistance vessles: roles of O2.- and endothelium. JVascRes 43: 109-119. (Pubitemid 41832713)
46. Verlander JW, Kim YH, Shin W, Pham TD, Hassell KA, et al. (2006) Dietary Cl(-) restriction upregulates pendrin expression within the apical plasma membrane of type B intercalated cells. Am J Physiol Renal Physiol 291: F833-839. (Pubitemid 44506980)
47. Turla MB, Thompson MM, Corjay MH, Owens GK (1991) Mechanisms of angiotensin II- and arginine vasopressin-induced increases in protein synthesis and content in cultured rat aortic smooth muscle cells. CircRes 68: 288-299.